Showing 1 - 7 results of 7 for search 'Risako Yasuda', query time: 0.03s Refine Results
  1. 1
    Sarco/Endoplasmic Reticulum Ca<sup>2+</sup> ATPase 2 Activator Ameliorates Endothelial Dysfunction; Insulin Resistance in Diabetic Mice

    Sarco/Endoplasmic Reticulum Ca<sup>2+</sup> ATPase 2 Activator Ameliorates Endothelial Dysfunction; Insulin Resistance in Diabetic Mice by Toyokazu Kimura, Kazuki Kagami, Atsushi Sato, Ayumu Osaki, Kei Ito, Shunpei Horii, Takumi Toya, Nobuyuki Masaki, Risako Yasuda, Yuji Nagatomo, Takeshi Adachi

    Published 2022-04-01
    Get full text
    Article
  2. 2
    Sex Differences in Cardiac and Clinical Phenotypes and Their Relation to Outcomes in Patients with Heart Failure

    Sex Differences in Cardiac and Clinical Phenotypes and Their Relation to Outcomes in Patients with Heart Failure by Akane Kawai, Yuji Nagatomo, Midori Yukino-Iwashita, Ryota Nakazawa, Yusuke Yumita, Akira Taruoka, Asako Takefuji, Risako Yasuda, Takumi Toya, Yukinori Ikegami, Nobuyuki Masaki, Takeshi Adachi

    Published 2024-02-01
    Get full text
    Article
  3. 3
    Short-Chain Fatty Acids in Gut–Heart Axis: Their Role in the Pathology of Heart Failure

    Short-Chain Fatty Acids in Gut–Heart Axis: Their Role in the Pathology of Heart Failure by Midori Yukino-Iwashita, Yuji Nagatomo, Akane Kawai, Akira Taruoka, Yusuke Yumita, Kazuki Kagami, Risako Yasuda, Takumi Toya, Yukinori Ikegami, Nobuyuki Masaki, Yasuo Ido, Takeshi Adachi

    Published 2022-11-01
    Get full text
    Article
  4. 4
    β<sub>1</sub> Adrenergic Receptor Autoantibodies and IgG Subclasses: Current Status and Unsolved Issues

    β<sub>1</sub> Adrenergic Receptor Autoantibodies and IgG Subclasses: Current Status and Unsolved Issues by Akane Kawai, Yuji Nagatomo, Midori Yukino-Iwashita, Ryota Nakazawa, Akira Taruoka, Yusuke Yumita, Asako Takefuji, Risako Yasuda, Takumi Toya, Yukinori Ikegami, Nobuyuki Masaki, Yasuo Ido, Takeshi Adachi

    Published 2023-09-01
    Get full text
    Article
  5. 5
    The Safety and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors for Patients with Sarcopenia or Frailty: Double Edged Sword?

    The Safety and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors for Patients with Sarcopenia or Frailty: Double Edged Sword? by Ayami Naito, Yuji Nagatomo, Akane Kawai, Midori Yukino-Iwashita, Ryota Nakazawa, Akira Taruoka, Asako Takefuji, Risako Yasuda, Takumi Toya, Yukinori Ikegami, Nobuyuki Masaki, Yasuo Ido, Takeshi Adachi

    Published 2024-01-01
    Get full text
    Article
  6. 6
    Impact of oxidative posttranslational modifications of SERCA2 on heart failure exacerbation in young patients with non-ischemic cardiomyopathy: A pilot study

    Impact of oxidative posttranslational modifications of SERCA2 on heart failure exacerbation in young patients with non-ischemic cardiomyopathy: A pilot study by Takumi Toya, Kei Ito, Kazuki Kagami, Ayumu Osaki, Atsushi Sato, Toyokazu Kimura, Shunpei Horii, Risako Yasuda, Takayuki Namba, Yasuo Ido, Yuji Nagatomo, Katsumi Hayashi, Nobuyuki Masaki, Hirotaka Yada, Takeshi Adachi

    Published 2020-02-01
    Get full text
    Article
  7. 7
    D-Dimer beyond Diagnosis of Pulmonary Embolism: Its Implication for Long-Term Prognosis in Cardio-Oncology Era

    D-Dimer beyond Diagnosis of Pulmonary Embolism: Its Implication for Long-Term Prognosis in Cardio-Oncology Era by Masafumi Himeno, Yuji Nagatomo, Akira Miyauchi, Aimi Sakamoto, Keita Kiyose, Midori Yukino-Iwashita, Akane Kawai, Tsukasa Naganuma, Satonori Maekawara, Ayami Naito, Kazuki Kagami, Yusuke Yumita, Risako Yasuda, Takumi Toya, Yukinori Ikegami, Nobuyuki Masaki, Takeshi Adachi

    Published 2023-01-01
    Get full text
    Article

Search Tools: